Pharming Group Nv Stock Market Value
| PHAR Stock | USD 9.32 0.05 0.54% |
| Symbol | Pharming |
Pharming Group NV Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pharming Group. If investors know Pharming will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pharming Group listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.61) | Earnings Share (0.27) | Revenue Per Share 4.38 | Quarterly Revenue Growth 0.122 | Return On Assets (0.01) |
The market value of Pharming Group NV is measured differently than its book value, which is the value of Pharming that is recorded on the company's balance sheet. Investors also form their own opinion of Pharming Group's value that differs from its market value or its book value, called intrinsic value, which is Pharming Group's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pharming Group's market value can be influenced by many factors that don't directly affect Pharming Group's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pharming Group's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pharming Group is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pharming Group's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Pharming Group 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Pharming Group's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Pharming Group.
| 12/23/2022 |
| 12/12/2024 |
If you would invest 0.00 in Pharming Group on December 23, 2022 and sell it all today you would earn a total of 0.00 from holding Pharming Group NV or generate 0.0% return on investment in Pharming Group over 720 days. Pharming Group is related to or competes with Eliem Therapeutics, Genenta Science, Opthea, Mineralys Therapeutics,, Anebulo Pharmaceuticals, Janux Therapeutics, and Rezolute. Pharming Group N.V., a biopharmaceutical company, develops and commercialize protein replacement therapies and precision... More
Pharming Group Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Pharming Group's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Pharming Group NV upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.34 | |||
| Information Ratio | 0.1042 | |||
| Maximum Drawdown | 13.75 | |||
| Value At Risk | (5.26) | |||
| Potential Upside | 5.81 |
Pharming Group Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Pharming Group's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Pharming Group's standard deviation. In reality, there are many statistical measures that can use Pharming Group historical prices to predict the future Pharming Group's volatility.| Risk Adjusted Performance | 0.11 | |||
| Jensen Alpha | 0.5693 | |||
| Total Risk Alpha | (0.07) | |||
| Sortino Ratio | 0.1044 | |||
| Treynor Ratio | (0.50) |
Pharming Group NV Backtested Returns
Pharming Group appears to be not too volatile, given 3 months investment horizon. Pharming Group NV maintains Sharpe Ratio (i.e., Efficiency) of 0.12, which implies the firm had a 0.12% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Pharming Group NV, which you can use to evaluate the volatility of the company. Please evaluate Pharming Group's Semi Deviation of 2.93, risk adjusted performance of 0.11, and Coefficient Of Variation of 707.02 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Pharming Group holds a performance score of 9. The company holds a Beta of -0.93, which implies possible diversification benefits within a given portfolio. As the market becomes more bullish, returns on owning Pharming Group are expected to decrease slowly. On the other hand, during market turmoil, Pharming Group is expected to outperform it slightly. Please check Pharming Group's standard deviation, expected short fall, period momentum indicator, as well as the relationship between the maximum drawdown and rate of daily change , to make a quick decision on whether Pharming Group's historical price patterns will revert.
Auto-correlation | 0.22 |
Weak predictability
Pharming Group NV has weak predictability. Overlapping area represents the amount of predictability between Pharming Group time series from 23rd of December 2022 to 18th of December 2023 and 18th of December 2023 to 12th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Pharming Group NV price movement. The serial correlation of 0.22 indicates that over 22.0% of current Pharming Group price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.22 | |
| Spearman Rank Test | 0.2 | |
| Residual Average | 0.0 | |
| Price Variance | 2.89 |
Pharming Group NV lagged returns against current returns
Autocorrelation, which is Pharming Group stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Pharming Group's stock expected returns. We can calculate the autocorrelation of Pharming Group returns to help us make a trade decision. For example, suppose you find that Pharming Group has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Pharming Group regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Pharming Group stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Pharming Group stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Pharming Group stock over time.
Current vs Lagged Prices |
| Timeline |
Pharming Group Lagged Returns
When evaluating Pharming Group's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Pharming Group stock have on its future price. Pharming Group autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Pharming Group autocorrelation shows the relationship between Pharming Group stock current value and its past values and can show if there is a momentum factor associated with investing in Pharming Group NV.
Regressed Prices |
| Timeline |
Additional Tools for Pharming Stock Analysis
When running Pharming Group's price analysis, check to measure Pharming Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharming Group is operating at the current time. Most of Pharming Group's value examination focuses on studying past and present price action to predict the probability of Pharming Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharming Group's price. Additionally, you may evaluate how the addition of Pharming Group to your portfolios can decrease your overall portfolio volatility.